Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 1
1998 1
1999 2
2000 1
2003 1
2004 1
2005 2
2006 2
2007 2
2008 2
2009 3
2010 4
2011 4
2012 3
2013 4
2014 2
2016 1
2018 1
2021 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Schwannomatosis: the overlooked neurofibromatosis?
Koontz NA, Wiens AL, Agarwal A, Hingtgen CM, Emerson RE, Mosier KM. Koontz NA, et al. Among authors: hingtgen cm. AJR Am J Roentgenol. 2013 Jun;200(6):W646-53. doi: 10.2214/AJR.12.8577. AJR Am J Roentgenol. 2013. PMID: 23701098 Review.
Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.
Wolters PL, Martin S, Merker VL, Gardner KL, Hingtgen CM, Tonsgard JH, Schorry EK, Baldwin A; REiNS International Collaboration. Wolters PL, et al. Among authors: hingtgen cm. Neurology. 2013 Nov 19;81(21 Suppl 1):S6-14. doi: 10.1212/ Neurology. 2013. PMID: 24249806 Free PMC article. Review.
Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.
Wilson SM, Schmutzler BS, Brittain JM, Dustrude ET, Ripsch MS, Pellman JJ, Yeum TS, Hurley JH, Hingtgen CM, White FA, Khanna R. Wilson SM, et al. Among authors: hingtgen cm. J Biol Chem. 2012 Oct 12;287(42):35065-35077. doi: 10.1074/jbc.M112.378695. Epub 2012 Aug 13. J Biol Chem. 2012. PMID: 22891239 Free PMC article.
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.
Wolters PL, Martin S, Merker VL, Tonsgard JH, Solomon SE, Baldwin A, Bergner AL, Walsh K, Thompson HL, Gardner KL, Hingtgen CM, Schorry E, Dudley WN, Franklin B; REiNS International Collaboration. Wolters PL, et al. Among authors: hingtgen cm. Neurology. 2016 Aug 16;87(7 Suppl 1):S4-S12. doi: 10.1212/WNL.0000000000002927. Neurology. 2016. PMID: 27527648 Free PMC article.
Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.
Wolters PL, Vranceanu AM, Thompson HL, Martin S, Merker VL, Baldwin A, Barnett C, Koetsier KS, Hingtgen CM, Funes CJ, Tonsgard JH, Schorry EK, Allen T, Smith T, Franklin B, Reeve S; REiNS International Collaboration. Wolters PL, et al. Among authors: hingtgen cm. Neurology. 2021 Aug 17;97(7 Suppl 1):S50-S63. doi: 10.1212/WNL.0000000000012421. Epub 2021 Jul 6. Neurology. 2021. PMID: 34230198 Free PMC article.
Stroke code simulation benefits advanced practice providers similar to neurology residents.
Khan M, Baird GL, Price T, Tubergen T, Kaskar O, De Jesus M, Zachariah J, Oostema A, Scurek R, Coleman RR, Sherman W, Hingtgen C, Abdelhak T, Smith B, Silver B. Khan M, et al. Among authors: hingtgen c. Neurol Clin Pract. 2018 Apr;8(2):116-119. doi: 10.1212/CPJ.0000000000000435. Neurol Clin Pract. 2018. PMID: 29708218 Free PMC article.
Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.
Merker VL, Thompson HL, Wolters PL, Buono FD, Hingtgen CM, Rosser T, Barton B, Barnett C, Smith T, Haberkamp D, McManus ML, Baldwin A, Moss IP, Röhl C, Martin S. Merker VL, et al. Among authors: hingtgen cm. Clin Trials. 2024 Feb;21(1):6-17. doi: 10.1177/17407745231205577. Epub 2023 Dec 23. Clin Trials. 2024. PMID: 38140900 Free PMC article.
Neurofibromin-deficient myeloid cells are critical mediators of aneurysm formation in vivo.
Li F, Downing BD, Smiley LC, Mund JA, Distasi MR, Bessler WK, Sarchet KN, Hinds DM, Kamendulis LM, Hingtgen CM, Case J, Clapp DW, Conway SJ, Stansfield BK, Ingram DA Jr. Li F, et al. Among authors: hingtgen cm. Circulation. 2014 Mar 18;129(11):1213-24. doi: 10.1161/CIRCULATIONAHA.113.006320. Epub 2013 Dec 26. Circulation. 2014. PMID: 24370551 Free PMC article.
40 results